Taken together with the finding that ALT, which was already elevated in the SS group (Table 1), is the parameter most strongly associated with IRS-2/PEPCK/G6Pase expressions (Table 3), selective insulin resistance associated with IRS-2 downregulation is likely to occur in the early stages of NAFLD. The gene discussed is PCK2; the disease is metabolic dysfunction-associated steatotic liver disease.